Table 1.

Cell-cycle progression of FA-D2 transfectants

TreatmentTime after release (h)PD20-FANCD2 (wt)PD20-FANCD2 (K561R)PD20-pMMP
G1SG2/MG1SG2/MG1SG2/M
−MMC 83.7 12.4 3.9 79.1 16.0 4.9 81.4 12.8 5.8 
 2.9 86.0 11.1 0.0 94.2 5.8 9.8 87.3 2.9 
 2.0 16.0 82.0 2.6 18.3 79.1 5.1 10.1 84.8 
 12 42.3 10.1 47.6 45.4 8.4 46.2 45.6 11.1 43.3 
+MMC 79.2 18.7 2.1 81.9 14.7 3.4 80.6 14.9 4.5 
 1.7 87.0 11.3 9.7 85.7 4.6 2.3 88.0 9.7 
 2.2 16.1 81.7 2.1 20.1 77.8 2.5 20.4 77.1 
 12 5.4 11.4 83.2 2.9 9.1 88.1 3.8 9.0 87.2 
TreatmentTime after release (h)PD20-FANCD2 (wt)PD20-FANCD2 (K561R)PD20-pMMP
G1SG2/MG1SG2/MG1SG2/M
−MMC 83.7 12.4 3.9 79.1 16.0 4.9 81.4 12.8 5.8 
 2.9 86.0 11.1 0.0 94.2 5.8 9.8 87.3 2.9 
 2.0 16.0 82.0 2.6 18.3 79.1 5.1 10.1 84.8 
 12 42.3 10.1 47.6 45.4 8.4 46.2 45.6 11.1 43.3 
+MMC 79.2 18.7 2.1 81.9 14.7 3.4 80.6 14.9 4.5 
 1.7 87.0 11.3 9.7 85.7 4.6 2.3 88.0 9.7 
 2.2 16.1 81.7 2.1 20.1 77.8 2.5 20.4 77.1 
 12 5.4 11.4 83.2 2.9 9.1 88.1 3.8 9.0 87.2 

Indicated PD20 (FA-D2) fibroblast transfectants were arrested at G1/S using double-thymidine block and were released into S phase.

Cell-cycle progression was analyzed by DNA flow histograms of propidium iodide–stained cells.

or Create an Account

Close Modal
Close Modal